Invivyd IVVD
NASDAQ IVVD
$0.62 -0.02 (-3.79%)
As of: Oct 22, 2026 · 10:34 AM EDT

Invivyd (IVVD) EBITDA Margin (2024 - 2025)

Updated

Invivyd (IVVD) posted EBITDA Margin of -72.10% for Q4 2025, up 59.20 percentage points from -131.30% a year earlier and up 10.73 percentage points from the prior quarter.

Analysis

Invivyd (IVVD) EBITDA Margin (2024 - 2025) Analysis & Trends

For FY2025, Invivyd's EBITDA Margin came in at -102.58%, up 588.44 percentage points from FY2024.

  • In prior years, Invivyd's EBITDA Margin was -691.03% in FY2024.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -82.82% (Q3 2025), -126.50% (Q2 2025) and -146.99% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,164.36 Bn 1,132.95 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 634.54 Bn 553.07 Bn 17.26 Bn 35.95%
3 AbbVie 502.85 Bn 475.96 Bn 12.70 Bn 49.01%
4 Merck 376.50 Bn 330.88 Bn 12.21 Bn 6.02%
5 Novartis Ag 303.65 Bn 267.64 Bn 11.24 Bn -
6 Astrazeneca 266.62 Bn 240.30 Bn 12.86 Bn 33.11%
7 Amgen 241.17 Bn 196.57 Bn 7.24 Bn 46.01%
8 Gilead Sciences 193.39 Bn 167.59 Bn 6.22 Bn -124.26%
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn 39.16%
10 Invivyd 199.76 Mn -306.88 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -72.10%
Sep 30, 2025 -82.82%
Jun 30, 2025 -126.50%
Mar 31, 2025 -146.99%
Dec 31, 2024 -131.30%
Sep 30, 2024 -668.59%
Jun 30, 2024 -2,169.57%
API Access

Invivyd EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY